Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Man Group PLC : Form 8.3 - Crest Nicholson Holdings plc
-
Man Group PLC : Form 8.3 - Bellway plc
-
Man Group PLC : Form 8.3 - Keywords Studios plc
-
Invesco Ltd: Form 8.3 - Bellway PLC
-
Man Group PLC : Form 8.3 - International Paper Company
-
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa
-
Freshpet, Inc. Reports Second Quarter 2024 Financial Results
-
Quantum Capital Group to Acquire Cogentrix from Carlyle for $3 Billion
-
Verano to Welcome Ohio Adult Use Cannabis Customers on August 6th at Company’s Zen Leaf Dispensaries to Commemorate Historic End of Cannabis Prohibition in the Buckeye State
-
Man Group PLC : Form 8.3 - Redrow plc
-
Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Golar and bp enter into commercial reset arrangements for FLNG Gimi
-
Golar and bp enter into commercial reset arrangements for FLNG Gimi
-
Kronos Advanced Technologies Inc. and Yasheng Group Announce Strategic Collaboration to Develop Revolutionary Nuclear Battery.
-
Nanoflex Robotics Appoints Per Vegard Nerseth, Former CMR Surgical CEO, as Non-Executive Director
-
H World Group Limited Schedules Second Quarter and Interim of 2024 Earnings Release on August 20, 2024
-
Gran Tierra Energy Inc. Announces Positive Test Results from Bocachico Norte-J1
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Keywords Studios plc
-
Form 8.5 (EPT/RI) - Global Ports Holding Plc
-
Carlyle Secured Lending, Inc. Announces Merger with Carlyle Secured Lending III
-
Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended 2024, Declares Third Quarter 2024 Dividends of $0.47 Per Common Share and Announces Merger Agreement with Carlyle Sec
-
Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
-
Scatec and Aeolus, part of Toyota Tsusho Group, join forces for Tunisia solar projects
-
Strainsforpains-EBYH, CEO Simon Shainberg Signs Strategic Product Commercialization Agreement with Cannabis Science; Shainberg’s 2024 Guidance Projects Strong Revenue Growth For Its Multiplied Canna
-
Agora, Inc. to Report Second Quarter 2024 Financial Results on August 19, 2024
-
PROVOKE SOLUTIONS APPOINTS FORMER META VISIONARY HARPER CARROLL AS STRATEGIC ADVISOR
-
Johnson Outdoors Reports Fiscal Third Quarter Results
-
Philips to repurchase shares for up to EUR 125 million to cover long-term incentive plans
-
QUADIENT: Quadient 2.25% notes: Outstanding nominal amount on 31 July 2024
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
-
Genmab Takes Full Control of Acasunlimab Development Program
-
Share buyback programme - week 31
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
Net Asset Value(s)
-
Shareholding as 07/31/2024
-
Transactions in connection with share buyback programme
-
Investeringsforeningen Sparinvest suspenderer handel med udvalgte afdelinger
-
Jackson Square Properties and Russell Square Secure Entitlements for Delta Shores Development in Sacramento
-
Aurora Mobile Partners with Bank of Zhangjiakou to Accelerate Digital Transformation
-
Prepayments, Realkredit Danmark A/S
-
Sydbank share buyback programme: transactions in week 31
-
Form 8.5 (EPT/RI) - Alpha Financial Markets Consulting Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VIRGIN MONEY UK PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Form 8.5 (EPT/RI) - Renalytix Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BELLWAY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc.
